HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 27.12
+0.59 (2.22%)
At close: Mar 6, 2026
HitGen Market Cap
HitGen has a market cap or net worth of 10.83 billion as of March 6, 2026. Its market cap has increased by 84.99% in one year.
Market Cap
10.83B
Enterprise Value
10.08B
Revenue
525.57M
Ranking
n/a
PE Ratio
96.86
Stock Price
27.12
Market Cap Chart
Since April 16, 2020, HitGen's market cap has decreased from 18.86B to 10.83B, a decrease of -42.57%. That is a compound annual growth rate of -8.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.83B | 15.65% |
| Dec 31, 2025 | 9.37B | 90.34% |
| Dec 31, 2024 | 4.92B | -17.81% |
| Dec 29, 2023 | 5.99B | 10.86% |
| Dec 30, 2022 | 5.40B | -42.61% |
| Dec 31, 2021 | 9.41B | -22.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 11.88B |
| Staidson (Beijing) BioPharmaceuticals | 11.66B |
| InventisBio | 11.55B |
| Hualan Biological Vaccine | 11.25B |
| Beijing Hotgen Biotech | 10.78B |
| Chengzhi | 10.52B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.40B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.30B |